The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School: Diabetes Mellitus, Type 2 trials

The registry lists 16 Diabetes Mellitus, Type 2 studies with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 3No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive ImpairmentRecruitingNCT07650318Not applicable
• Transcutaneous Auricular Vagus Nerve Stimulation in Type 2 Diabetes With Mild Cognitive ImpairmentNot yet recruitingNCT07642518Not applicable
• Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLDRecruitingNCT07632677
• Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)RecruitingNCT07083154Phase 3
• Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin TabletsRecruitingNCT07023172
• Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM PatientsRecruitingNCT06217887Not applicable
• Risk Model of Cognitive Impairment in DiabetesRecruitingNCT05590442
• Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive ImpairmentRecruitingNCT05543967
• Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver DiseaseActive, not recruitingNCT07274644Phase 4
• Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive ImpairmentCompletedNCT06327633Not applicable
• Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical TrialCompletedNCT06085703Not applicable
• LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 DiabetesCompletedNCT05313529Not applicable
• Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.Status unknownNCT03961659Not applicable
• Observational Study of Drug Naive Diabetes Receiving Insulin TherapyStatus unknownNCT03710811
• Antidiabetic Effects on Intrahepatic FatCompletedNCT03068065Phase 4
• Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With MetforminCompletedNCT02280486Phase 4